IP Library Granted Patent US 11,504,221
Granted Patent B2
US 11,504,221 · App. 16/825,715 · Granted Nov 22, 2022

Biliary stents and methods

Inventors: Kenneth F. Binmoeller (San Francisco, CA); Sieu T. Duong (Hayward, CA); Hanh Duong (Hayward, CA); Thao Nguyen (San Jose, CA)
Assignee: Boston Scientific Scimed Inc.
A61F2/04A61F2/07A61F2/90A61F2002/041A61F2230/001A61F2230/0069A61F2230/0095A61F2250/0019
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,504,221
App. No.
16/825,715
Granted
Nov 22, 2022
Kind
B2
Abstract

A tissue lumen stent is provided with a body having an elongated tubular configuration and a foreshortened configuration. In the foreshortened configuration, downstream and upstream ends of the body expand radially into downstream and upstream flange structures, leaving a generally cylindrical saddle region therebetween. In some embodiments, the flange structures are non-symmetrical with respect to one another. Systems and methods of using the stents are also disclosed.

Claims (21)

1. A stent comprising a body having an elongated tubular configuration and a foreshortened configuration wherein a downstream end of the body expands into a downstream flange structure and an upstream end of the body expands into a flared flange structure, wherein a maximum outer diameter of the downstream flange structure is greater than twice a maximum axial length of the downstream flange structure, wherein a portion of the flared flange structure increases in diameter and another portion of the flared flange structure decreases in diameter, and wherein the downstream flange structure is a double-walled flange.

2. The stent of claim 1 , wherein the flared flange structure comprises a larger maximum lateral dimension than that of the downstream flange structure.

3. The stent of claim 1 , further comprising a saddle region between the downstream flange structure and flared flange structure.

4. The stent of claim 3 , further comprising a covering or membrane over the saddle region and the downstream flange structure.

5. The stent of claim 3 , further comprising a covering or membrane over the saddle region and the flared flange structure.

6. The stent of claim 4 , wherein the flared flange structure is uncovered.

7. The stent of claim 1 , wherein one or more of the downstream and flared flange structures have a pull-out force of greater than about 2.94 N.

8. A stent comprising a body having an elongated tubular configuration and a foreshortened configuration wherein a downstream end of the body expands into a downstream flange structure and an upstream end of the body expands into a flared flange structure leaving a saddle region therebetween, wherein an axial length of the flared flange structure is at least as long as an axial length of the saddle region, and wherein a distal end of the flared flange structure includes an inward curl.

9. The stent of claim 8 , wherein the flared flange structure comprises a larger maximum lateral dimension than that of the downstream flange structure.

10. The stent of claim 8 , wherein the downstream flange structure comprises a larger maximum axial width than the flared flange structure.

11. The stent of claim 8 , further comprising a covering or membrane over the body of the stent.

12. The stent of claim 11 , wherein the covering extends over the downstream flange structure.

13. The stent of claim 11 , wherein the covering extends over the flared flange structure.

14. The stent of claim 11 , wherein the flared flange structure is uncovered and the downstream flange structure is covered.

15. A method of treating a patient, comprising:

accessing a biliary system of a patient with a delivery catheter; and

deploying from the delivery catheter, within the biliary system of the patient, a stent having a foreshortened configuration defining an upstream flared flange structure, a downstream flange structure and a cylindrical portion extending therebetween, wherein a maximum outer diameter of the downstream flange structure is greater than twice a maximum axial length of the downstream flange structure, wherein a portion of the flared flange structure increases in diameter and another portion of the flared flange structure decreases in diameter, and wherein a distal end of the flared flange structure includes an inward curl.

16. The method of claim 15 , wherein the stent contacts a lumen selected from the group consisting of the common bile duct, the pancreatic duct, and the hepatic duct.

17. The stent of claim 1 , wherein a distal end of the flared flange structure includes an inward curl.

18. The stent of claim 8 , wherein one or more of the downstream and flared flange structures have a pull-out force of greater than about 2.55 N.

19. The method of claim 15 , wherein one or more of the downstream and flared flange structures have a pull-out force of greater than about 2.55 N.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2020
From: BINMOELLER, KENNETH F.; DUONG, SIEU T.; DUONG, HANH H.; NGUYEN, THAO
To: XLUMENA, INC.
Reel/Frame 053402/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2020
From: XLUMENA, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 053402/0598 →
Continuity (4)
Continuation 16009619 · Jun 15, 2018
Continuation 14743191 · Jun 18, 2015
Provisional Application 62013908 · Jun 18, 2014
Related Publication 20200214823A1 · Jul 9, 2020